Clinical trials
Tuberculosis, Pulmonary trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 1 |
| Centers for Disease Control and Prevention | 1 |
| Centro Universitário Augusto Motta | 1 |
| Federal University of Mato Grosso | 1 |
| Federal University of Uberlandia | 1 |
| Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 1 |
| Gates Medical Research Institute | 1 |
| Global Alliance for TB Drug Development | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Pulmonary | 13 |
| Tuberculosis | 5 |
| HIV Infections | 2 |
| Tuberculosis, Multidrug-Resistant | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Tuberculosis, Extrapulmonary | 1 |
Trials
Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.